Post by PPD

⚖️ Obesity drug development is evolving rapidly, and demonstrating efficacy is no longer enough. Today's sponsors face increasing pressure to generate evidence that resonates with regulators, payers and patients alike. Success requires thoughtful endpoint selection, patient-centric trial design and strategies that demonstrate real-world value beyond weight loss. Join our experts as we explore practical approaches to designing obesity trials that support regulatory approval, market access and long-term patient impact. 📅 Register for our upcoming webinar: http://spr.ly/6045BEGS0P